Utah plans to allow an AI product to evaluate patients and write new drug prescriptions without prior human review.
Vaxcyte disclosed that its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a ...
The Trump administration released new regulations Monday that will force health insurance companies to publish cleaned-up spreadsheets of the prices that they pay hospitals and do ...
Vaxcyte said its experimental pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up the ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
What science says so far about which cancers can be beat by vaccines — and which will require more creative approaches.
John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — The upcoming midterm ...
Jeremy Faust cuts through a hallway of Boston’s Brigham and Women’s Hospital on his way to see a patient who is struggling to breathe. It’s the start of his evening shift, and the emergency department ...
Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations ...
News of a fifth measles death in Pennsylvania underscores a longstanding issue about the disease. The full scope of the ...
Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results